用于癌症患者长期静脉注射治疗的血管通路装置。

IF 8.8 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cochrane Database of Systematic Reviews Pub Date : 2024-08-30 DOI:10.1002/14651858.CD015667

Caitriona Duggan, Peter J Carr, Nicole Gavin, Stewart Walsh, Andrew Simpkin, Joshua Byrnes, Christina H Ruhlmann, Raymond J Chan, Orlaith Hernon

引用次数: 0

摘要

目标：这是一份科克伦综述（干预）协议。目标如下：评估需要长期全身性抗癌治疗的患者使用血管通路装置（VAD）的相对有效性以及与之相关的并发症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Vascular access devices for prolonged intravenous therapy regimens in people diagnosed with cancer.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the relative effectiveness and vascular access device (VAD)-related complications of VADs in people requiring prolonged systemic anti-cancer treatment.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cochrane Database of Systematic Reviews 医学-医学：内科

CiteScore

10.60

自引率

2.40%

发文量

173

审稿时长

1-2 weeks

期刊介绍： The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.